Stocksigma LogoStocksigma Logo

Beacon Trusteeship Discloses 5.44% Equity Encumbrance in Symbiotec Pharmalab

Beacon Trusteeship Limited, acting as debenture trustee for NCDs issued by Satwani Holdings (India) Private Limited, created an encumbrance over 3,493,464

Beacon Trusteeship Discloses 5.44% Equity Encumbrance in Symbiotec Pharmalab

Symbiotec Pharmalab Ltd 路 Acquisition/ Disposal of Shares 路 11 Sept 2026, 6:00 pm

Beacon Trusteeship Discloses 5.44% Equity Encumbrance in Symbiotec Pharmalab Beacon Trusteeship Limited, acting as debenture trustee for NCDs issued by Satwani Holdings (India) Private Limited, created an encumbrance over 3,493,464 equity shares of Symbiotec Pharmalab Limited. This represents 5.44% of total share capital and 5.43% of diluted share capital. The pledged shares, created between 8th Sep'26 and 9th Sep'26, comprise holdings from promoter group members: Satwani Holding LLP (3.47%), Kashish Satwani (0.78%), Anil Satwani (0.70%), and Sushil Satwani (0.49%) to secure debt obligations under the debenture trust deed.

Original exchange filing (PDF)

More announcements from Symbiotec Pharmalab Ltd

All Symbiotec Pharmalab Ltd announcements